The FDA has finalized guidelines that govern off-label information sharing.
The FDA document states that doctors should be made aware of experimental uses for drugs and devices -- even if regulators have not approved them.
"The public health may be advanced by healthcare professionals' receipt of medical journal articles ... on unapproved new uses," the agency states. Such uses may even "constitute a medically recognized standard of care," according to the agency.
Knowledge is power. And information saves lives.
